Improving the reporting of allergic adverse events during immunotherapy for food allergy
Por:
Turner PJ, Patel N, Mäkelä MJ, Kukkonen K, Deschildre A, Blumchen K, Rodríguez Del Río P, Fernández-Rivas M, Alvaro-Lozano M and Beyer K
Publicada:
1 nov 2022
Ahead of Print:
1 nov 2022
Resumen:
Filiaciones:
Turner PJ:
National Heart &
amp
Lung Institute, Imperial College London, London, United Kingdom
Patel N:
National Heart &
amp
Lung Institute, Imperial College London, London, United Kingdom
Mäkelä MJ:
Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki,Helsinki, Finland
Kukkonen K:
Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Deschildre A:
CHU Lille, Univ. Lille, Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, Lille, France
Blumchen K:
Department of Paediatric and Adolescent Medicine, Pneumology, Allergology and Cystic fibrosis, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
Rodríguez Del Río P:
Hospital Universitario Niño Jesús, ARADyAL, Madrid, Spain
Fernández-Rivas M:
Allergy Department, Hospital Clínico San Carlos, Facultad de Medicina, Universidad Complutense (UCM), IdISSC, ARADyAL, Madrid
Alvaro-Lozano M:
Institut de Recerca Sant Joan de Déu
Universitat de Barcelona, Spain
Pediatric Allergology and Clinical Immunology Hospital Sant Joan de Déu
Beyer K:
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universtãtsmedizin Berlin, Berlin, Germany
|